Dr John Doupis is a former clinical research fellow of the Joslin Diabetes Center, Harvard Medical School, in Boston, MA, USA and scientific partner in Beth Israel Deaconess Foot Center Harvard Medical School, Boston, MA. Currently, he is directing the Diabetes Division and Clinical Research Center of Iatriko P. Falirou Medical Center in Athens, Greece. He has served as a principal investigator in many multicentre phase I, II, III and IV clinical trials, most of which have been published in international journals or presented at congresses. He is a registered reviewer and a member of the editorial board for many major diabetes medical journals. He has given numerous lectures in national and international congresses, presenting over 200 abstracts. His special areas of interest are diabetes and its complications, especially obesity, diabetic neuropathy, diabetic foot, as well as the glucose sensing technologies and insulin pumps. In these fields, he has published more than 50 papers in international medical journals, having more than 1,500 citations.

Prof. Chantal Mathieu is a physician-scientist who has contributed to the field of diabetes and endocrinology through basic and clinical research. Her basic research work focuses on pathogenesis and prevention of type 1 diabetes. Prof. Mathieu’s clinical work involving new products and treatment paradigms in diabetes, such as new insulins, adjunct therapies and diagnosis of gestational diabetes have made her a speaker in international fora. Prof. Mathieu coordinates the European clinical trial network for interventions in type 1 diabetes ‘INNODIA’ and the European project ‘EDENT1FI’ on screening for type 1 diabetes. Prof. Mathieu is president of EASD and vice-president of the European Diabetes Forum.

Diana Isaacs, PharmD, BCPS, BC-ADM, BCACP, CDCES is the Continuous Glucose Monitoring (CGM) Program Coordinator and Endocrinology Clinical Pharmacy Specialist at the Cleveland Clinic Diabetes Center. She provides medication management and runs a robust CGM shared medical appointment program. Dr Isaacs is a Certified Diabetes Care and Education Specialist and holds board certifications in pharmacotherapy, ambulatory care and advanced diabetes management. She has numerous diabetes publications and research projects with a focus on medications, CGM and diabetes technology.

Linda Siminerio, RN, PhD is Emeritus Professor of Medicine and Professor of Nursing, Health and Community Systems at the University of Pittsburgh. She has led a career in diabetes research and education. An internationally recognized expert on self-management education and health care delivery models in both pediatric and adult populations, she serves as the Principal Investigator on many studies related to diabetes treatment.

Dr Siminerio has authored numerous publications and served as editor on several diabetes journals.  She was President of Health Care and Education, American Diabetes Association and Senior Vice President, International Diabetes Federation (IDF) and Past-Chair of the National Diabetes Education Program (NDEP). In these positions, she has organized and led national and international efforts on the development of programs, standards and care models directed toward health professionals, patients and the community.

Dr Siminerio served as organizing chair for the International Diabetes Federation (IDF) World Diabetes Congress and IDF translation research program, Building Research in Diabetes Global Environments and Systems (BRIDGES).

Ashley Grossman was awarded an Open Exhibition to St Catharine’s College, Cambridge, completed a degree in Psychology and Social Anthropology at the University of London, and then entered University College London where he received a First-Class degree in Anatomy, and the University Gold Medal from UCHMS. He became Professor of Neuroendocrinology at St. Bartholomew’s Hospital in 1993, then Professor of Endocrinology at the University of Oxford, and Senior Research Fellow of Green-Templeton College. He is currently Consultant in Neuroendocrine Tumours at the Royal Free Hospital, London, and is also Professor of Neuroendocrinology at Barts and the London School of Medicine. He has published more than 550 peer-reviewed papers and over 450 chapters and reviews, most recently on hypothalamic and pituitary tumours and endocrine oncology. He has been President of the ENEA, the Society for Endocrinology (2012-2014), Chairman of UKINETS (2010-2012), President of the Pituitary Society (2015-2016), and is President of Endotext.

Dr Alexander Miras graduated from medical school at Imperial College London, UK, and trained as a junior doctor and Specialist Registrar in Diabetes and Endocrinology in the London deanery rotations between 2002-2010. In 2010, he was awarded with a Medical Research Council (MRC) Clinical Research Training PhD fellowship, which enabled him to investigate the effects of bariatric surgery on food reward using functional neuroimaging and behavioural methodologies both in humans and rodents. He is currently a Senior Clinical Lecturer in Endocrinology at Imperial College London and interested in the mechanisms through which bariatric surgery and medical devices improve weight, metabolic control and diabetes-related microvascular complications.

Prof.  Joseph Pappachan is the clinical lead for research & innovation in Endocrinology & Metabolism at Lancashire Teaching Hospitals NHS Trust (LTHTR) and Clinical Chair to Diabetic Foot & Musculoskeletal Metabolic Research at Manchester Metropolitan University and Visiting Professor to Medical Research Unit of Kozhikode Medical College (India). He is also an Academic Advisor in Endocrinology to the University of Manchester Medical School. He has more than 125 academic publications to his credit.

Prof Neil Gittoes graduated in 1990 from the University of Birmingham with BSc (Hons), MBChB (Hons), and was later awarded a PhD in Molecular Endocrinology and was supported by a prestigious MRC Career Establishment Grant. He is currently Consultant Endocrinologist in Birmingham and Honorary Professor of Endocrinology at the University of Birmingham; he is Head of the Centre for Endocrinology, Diabetes and Metabolism. He leads the metabolic bone diseases unit in Birmingham and additionally leads a number of national work streams through the National Osteoporosis Society (NOS) as Trustee and Chair of the Clinical and Scientific Committee. He works closely with the Society for Endocrinology and Royal College of Physicians, leading on endocrinology aspects of Genomics in Mainstream Medicine. He is co-author of the NOS UK Vitamin D Guidelines and he further advises NICE on bone metabolism therapies and the British National Formulary on endocrine therapies. He has been honoured by award of the Goulstonian Lectureship at the Royal College of Physicians. Neil is Vice-Chairman of the Clinical Reference Group for Specialised Endocrinology, NHS England. He is also Vice-Chairman of Council of the West Midlands Clinical Senate. He has published widely and has lectured at many national and international conferences. He sits on editorial boards of four journals, with roles including Section Editor and Associate Editor; he has wide experience in multiple modalities of peer review. Neil’s main clinical and research interests focus on disorders of calcium homeostasis and rare causes of osteoporosis.

Dr. Chrousos has focused his research on the hypothalamic-pituitary-adrenal (HPA) axis and has extensively studied the neuroendocrine alterations associated with mood disorders, sleep, pain perception, and immune function.

According to the ISI, Dr. Chrousos is among the 200 most prominent clinical investigators in the world. He has authored more than 1000 scientific publications, has edited 23 books and his work has amassed over 40,000 citations.

Dr. Katznelson has a clinical and research interest in the pathophysiology and treatment of pituitary disease.

He is a member of the Editorial Board for Pituitary, and is an ad hoc reviewer for the Journal of Clinical Endocrinology and Metabolism. Dr. Katznelson recently served as Chair of the Special Programs Committee and a member of the Scientific and Educational Programs Core Committee in the Endocrine Society. He has served as an ad hoc member of NIH study sections.

Dr. Gharib is as an international authority on thyroid disorders.

Dr. Gharib has published 200+ peer reviewed articles and a number of books. Dr. Gharib has lectured more than 300 times at regional, national, or international endocrine events, and has been a visiting professor at 20 academic institutions in the U.S. and abroad.

Dr. Gharib is a Master of the American College of Physicians (M.A.C.P.) and a Master of the American College of Endocrinology (M.A.C.E.). He has been the recipient of many national and international awards, including the prestigious Paul Starr Award of the American Thyroid Association, the International Clinician Award of the Associazione Medici Endocrinologi, the Laureate Award of Mayo Clinic Department of Medicine, the Distinguished Physician Award of the Endocrine Society, and the Ellis Island Medal of Honor Award.

Dr. Gharib served as the President of the AACE in 2002, as the President of American College of Endocrinology in 2008, and has been the Dean of the Endocrine University since 2002. He is currently the President of the American Thyroid Association.

Dr. Saptarshi Bhattacharya is a senior consultant in the Department of Endocrinology at Indraprastha Apollo Hospitals, a premier tertiary care facility in Delhi, India. He completed his residency in endocrinology from All India Institute of Medical Sciences, Delhi. He has worked as a clinical endocrinologist in Delhi’s some of the major hospitals. He is an active member of various endocrine societies. He has organized several national and international conferences and conducted research methodology workshops. He is actively involved in research and is a DrNB teaching faculty for endocrine trainees. He has authored close to 80 articles in peer-reviewed journals.

Steven E. Nissen MD is Chief Academic Officer for the Heart and Vascular Institute at the Cleveland Clinic, the Lewis and Patricia Dickey Chair in Cardiovascular Medicine and Professor of Medicine at the Cleveland Clinic Lerner College of Medicine. From 2006 to 2019, he served as Chair of the Department of Cardiovascular Medicine at the Cleveland Clinic. In 2006-2007 he served as President of the American College of Cardiology (ACC).
He has served as Study Chairman for large global cardiovascular outcomes trials, most studying lipid modifying therapies. His contributions to scientific literature include more than 600 journal articles and 60 book chapters. He is co-author of a book for patients with heart disease, Heart411 released by Crown Books on January 31, 2012.
Dr. Nissen works closely with pharmaceutical companies on the development of new therapies for cardiovascular disease, but maintains a longstanding policy of requiring companies to donate all related honoraria directly to charity so that he receives neither income, nor a tax deduction.
In 2001, he co-authored the first manuscript (JAMA) that raised concerns about the cardiovascular safety of rofecoxib (Vioxx™), which was withdrawn from the market 3 years later. In 2007, he authored a NEJM manuscript that demonstrated that the widely used diabetes drug rosiglitazone (Avandia™) raised the risk of myocardial infarction, eventually leading in 2010 to withdrawal of the drug in Europe and severe restrictions in the US.
In 2007, Time Magazine selected Dr. Nissen as one of the world’s 100 most influential people. Beginning in 2015, he was named by Thompson-Reuters as one of the world’s most highly cited physician-scientists.

Steve Bain is the Clinical Director of the Diabetes Research Unit, Swansea University and Medical Director for Research & Development for Swansea Bay University Health Board.

Professor Bain completed his undergraduate training at St John’s College, Cambridge, and then was clinically trained at King’s College Hospital, London. On qualifying in 1983, he went on to hold junior appointments in London, the East Midlands, and the West Midlands, UK. His research centred on the genetics of type 1 diabetes, and he was granted a Medical Research Council Lectureship. In 1993, he became a Senior Lecturer/Honorary Consultant Physician at Birmingham Heartlands Hospital, Birmingham, with promotion to Reader in Diabetic Medicine in 1998. Professor Bain became a Fellow of the Royal College of Physicians UK in 1996 and was appointed to a newly created Chair in Medicine (Diabetes) in the University of Wales Swansea in 2005. His clinical interests include the genetics of diabetic nephropathy, new therapies for diabetes and the provision of diabetes services within the community. He has been Chief Investigator for many multi-centre trials investigating novel therapies for diabetes.

Professor Bain is the Diabetes Lead Clinician for the Swansea Bay University Health Board and a member of the Wales Diabetes & Endocrine Society (WEDS) executive committee. He chairs the Joint Clinical Research Facility in Swansea and was Clinical Director of the Academic Health Science Collaboration (AHSC) in Wales until September 2015. He chaired the Diabetes & Endocrinology Specialist Training Committee (STC) for Wales 2010-2017 and is currently Chair of the National Specialist Advisory Group (NSAG) for Diabetes in Wales.

Dr Brennan first undertook basic science training in Ireland with an undergraduate degree in biotechnology and immunology. Following this, he undertook a MRes in clinical neuroscience developing epidemiological insights into Motor Neurone Disease in Ireland.
He read medicine at the University of Dundee, achieving his degree in Medicine and Surgery, followed by clinical training in Yorkshire, Edinburgh and Dundee. He undertook doctoral research at the University of Edinburgh, whilst completing advanced hepatology training and developing a research thematic for a future post as a clinician-scientist.

Dr Ali read medicine at the University of Oxford, UK and undertook her specialist training in diabetes in North West London and Imperial College London. At Imperial College, she spent a year as a Clinical Research Fellow investigating eating behaviours and brain reward systems. She is now a Consultant Diabetologist at Royal Free London NHS Foundation Trust, where she is the Clinical Leads for both the Royal Free Diabetes Antenatal service and the Barnet Community Diabetes service.

Dr Ali’s specialist interests include integrated community diabetes care, diabetes in pregnancy, health inequalities in minority ethnic communities (diabetes and COVID-19), and diabetes in Ramadan, with publications in all of these fields.

Dr Ali strives to improve outcomes for people living with Diabetes; she is on the committee for the NICE Diabetes guidelines and has also undertaken a number of national diabetes projects, including co-authoring a national guideline on the best delivery of Diabetes in the PCNs on behalf of NHS England. Being a Trustee for the South Asian Health Foundation (SAHF) furthermore has allowed Sarah to help address health inequalities. She is due to become a Trustee for Diabetes UK in May 2022.

A passion for both science and the humanities keeps her balanced and harmonious. She is trilingual and a visual artist and colourist. Sarah creates contemporary/abstract medical art and working on a number of art projects to raise health awareness, including in diabetes. Dr Ali has exhibited art, sold paintings, created the artwork for a music cover album and has had a painting featured in Nature Medicine. She has recently created the artwork for a poetry collection about living with type 1 diabetes, which Sarah and her poet friend have published as a book Bittersweet. She is a Fellow of the Royal Society of Arts (FRSA).

Neely works as a Specialist Diabetes Podiatrist in Somerset Foundation NHS Trust. She has a specialist background in podiatric Surgery, biomechanics and diabetic wound care. Neely has an interest in innovation and well-being, she founded the No Hungry NHS Staff Campaign where she is currently campaigning nationally for 24/7 access to hot food for NHS Staff. Previously, Neely taught MSc students at Queen Mary’s University as a clinical educator.

Dr. Sanjay Kalra is an endocrinologist working at Bharti Hospital, Karnal, India. Executive Editor of the Indian Journal of Endocrinology & Metabolism, and Vice-President of South Asia Federation of Endocrine Societies, he remains busy in clinical care, patient education, research and medical writing. He has worked as Principal Investigator in >50 phase 1, 2 and 3 clinical trials, and won the global DAWN Award 2009 for best translational research in diabetes.

Professor Tesfaye’s research projects include the epidemiology, risk factors, pathogenesis, central nervous system involvement and treatment of diabetic neuropathy and neuropathic pain. He has published a book, over 25 book chapters and 100 original articles & reviews in the field of diabetic neuropathy.

Professor Tesfaye is Chairman of the International Expert Group on Diabetic Neuropathy that has published 7 consensus recommendation papers in 2010/11. He is the immediate past Chairman of NEURODIAB, the diabetic neuropathy study group of the European Association for the Study of Diabetes. He is the current Vice Chairman of the Science and Research Committee of Diabetes UK; a Board Member of the Global Quantitative Sensation Testing Society; a member of the Advisory Council of the Neuropathy Trust and a trustee of International Insulin Foundation.

Professor Tesfaye was recently awarded the prestigious Camillo Golgi Prize.

Professor Pacini is Chairman of the Department of Internal Medicine, Endocrinology and Metabolism, and Biochemistry at the University of Siena in Italy, Pacini is also President Elect of the European Thyroid Association. He is an expert in thyroid cancer. Professor Pacini has authored over 500 peer reviewed publications.

Anna-Lena Hulting is Professor of Endocrinology and Diabetology at the Karolinska Institute. She is also a senior doctor at the Department of Endocrinology, Metabolism and Diabetes at Karolinska University Hospital. Previously, Professor Hulting was Chief of the Department of Endocrinology and Diabetology, Karolinska Hospital. She has played an important role in the educational programme in endocrinology at Karolinska Institute since 1980. Between 2001 and 2003, Professor Hulting was Head of the Swedish Endocrine Society.

He is affiliated with a number of medical societies, including President of the International Society of Gynecological Endocrinology, President of the European Society of Gynecology, Past President of the International Menopause Society and member of the International Academy of Human Reproduction since 1993.

He is the recipient of many awards, including the Honoris Causa Laurea by the University of Wroclaw in Polonia in 1994, in 2005 he was awarded with the Honoris Causa Laurea by the University “Ovidius” of Costanta in Romania, in May 2007 he was awarded with the Honoris Causa Laurea by the University of Bucharest in Romania and in February 2009 he was awarded with the Honoris Causa Laurea by the University of Athens in Greece.

Professor Chiarelli’s research of interest includes molecular and cell biology of diabetic macroangiopathy, growth and growth factors, insulin resistance in children, abnormal puberty, early diagnosis of microangiopathy in children, obesity and type 2 diabetes in children.

He is often invited as a speaker in Europe, Japan, Australia, Asia and the United States. He is a prominent member of several societies, including the European Society of Paediatric Endocrinology (ESPE), the International Society for Pediatric and Adolescent Diabetes (ISPAD), the American Diabetes Association (ADA), the International Pediatric Association (IPA), the Italian Society of Pediatric Endocrinology and Diabetology (SIEDP). And ‘the Secretary General of the ESPE (2004-2011) was President of the ESPE in 2009 and 2013; is a member of the World Health Organization Task Force for Diabetes in the Child.

Virginia Valentine, CNS, BC-ADM, CDE, is Chief Executive Officer (CEO) and co-owner of Diabetes Network, Inc., an American Diabetes Association-recognized program, and a Clinical Nurse with more than 25 years experience in the management of diabetes.

Her published works include professional publications and books for patients, including Diabetes, Type 2 and What to Do. She is a member of the Advanced Practice Advisory Board to the New Mexico Board of Nursing and serves as President of the New Mexico Leadership Council of the American Diabetes Association.

In 1999, Ms. Valentine was awarded the Roche/Zitter Diabetes Disease Management Award, and is a past recipient of the Outstanding Diabetes Educator of the Year Award from the American Association of Diabetes Educators (AADE) and the 2006 recipient of the AADE Distinguished Service Award.

Dr. Lebovitz is an internationally recognized authority in the field of diabetes. He and his colleagues have contributed to the understanding of the pathogenesis of type 2 diabetes, particularly as it relates to ethic and racial differences, to mechanism of action and clinical utility of therapeutic agents used in the treatment of type 2 diabetes, and to the effects of body composition on insulin resistance and its associated abnormalities.

He has authored more than 200 peer reviewed articles and 75 book chapters.

Dr Lebovitz is affiliated with numerous societies, including American diabetes Association, the National Institutes of Health, and Veterans Administration. He has received many awards, including the Albert E. Renold Medal of the American Diabetes Association in 1994, the Samuel Moses Oration Award of the Research society for study of diabetes in India in 1993, and the Servier Medal of the Philippine Diabetes Association in 1999.

Dr LaFranchi’s clinical interests include childhood diabetes and disorders of growth, puberty, and thyroid disorders.

He has received many grants to fund research on various pediatric endocrine-related conditions. Dr. LaFranchi is widely published in peer-reviewed medical journals and has authored or coauthored numerous book chapters, abstracts, and medical papers. He was recognized as one of “The Best Doctors in America” by a selection of peers in 1994 through 2011.

Robert Knutzen is the CEO, Chairman of the Board and Co-founder of the Pituitary Network Association (PNA).

Working as an advocate on the behalf of pituitary patients, Mr. Knutzen has gained the support and respect of top medical professionals who recognize the importance of raising pituitary awareness.

Dr. Hamdy studies the cardiovascular benefits of short- and long-term weight reduction in obese individuals with and without type 2 diabetes.

Dr. Hamdy chaired the task force that developed Joslin’s new Clinical Nutrition Guidelines and is a member of the Nutrition Guidelines Committee of the American Association of Clinical Endocrinologists that created the AACE Nutrition Guidelines for Americans 2006.

Dr. Davis is the author of more than 110 peer-reviewed articles and 50 textbook chapters and review articles. His research focuses on mechanisms that defend against hypoglycemia.

He has been recognized with many distinguished awards throughout his career, including the Novartis Award for Diabetes Research in 2000 – considered to be the highest honor in that field of research. He was named a Fellow of the American College of Physicians in 2009, a Fellow of the American College of Endocrinologists in 2008 and a Fellow of the Royal College of Physicians in 2001.

Dr Davies has published over 400 peer reviewed scientific papers mostly in the area of thyroid disease.

Dr. Davies has received many honors in his career, is a member of the American Association of Physicians and is the President-Elect of the American Thyroid Association.

Dr. Dagogo-Jack’s research interests include the pathobiology of pre-diabetes, diabetes prevention, and the regulation of leptin in humans.

Dr. Dagogo-Jack has authored 200+ peer reviewed articles and 16 book chapters.

He has been elected to the Alpha Omega Alpha Medical Honor Society, and is a Fellow of the Royal College of Physicians of London, the American College of Physicians and the American College of Endocrinology. He is a past President of the American Diabetes Association (St Louis Chapter, 1998-2000), and past chair, Endocrinology Section, Central Society for Clinical Research (1999-2001). Dr. Dagogo-Jack is an active member of the Endocrine Society and the American Association of Clinical Endocrinologists. Dr. Dagogo-Jack is the recipient of the 2008 Distinction in Clinical Endocrinology Award from the American College of Endocrinology and the 2009 Meritorious Achievement Award from the National Medical Association.

Dr. Chrousos has focused his research on the hypothalamic-pituitary-adrenal (HPA) axis and has extensively studied the neuroendocrine alterations associated with mood disorders, sleep, pain perception, and immune function.

According to the ISI, Dr. Chrousos is among the 200 most prominent clinical investigators in the world. He has authored more than 1000 scientific publications, has edited 23 books and his work has amassed over 40,000 citations.

Dr Camacho has published three books on endocrinology: Evidence Based Endocrinology, Osteoporosis: A Guide for Clinicians, and A Color Handbook of Clinical Endocrinology and Metabolism. She has authored numerous publications and presented in national and international meetings.

She is Vice-President of the American Association of Clinical Endocrinologists and is on the editorial board of Endocrine Practice and Journal of Clinical Densitometry.

Dr. Bode is a diabetes specialist who has authored 200+ peer reviewed publications.

He has served on the board of directors of the Georgia chapters of the Juvenile Diabetes Research Foundation, the American Diabetes Association (ADA), and the Georgia diabetes camps. He is a past president of the ADA Georgia Affiliate, editor of the ADA’s 2004 edition of Medical Management of Type 1 Diabetes, and a fellow of the American College of Endocrinology.

Dr. Braunstein’s research interests are in the fields of reproductive endocrinology with extensive basic and clinical studies on the placental hormone human chorionic gonadotropin and thyroid cancer.

Dr. Braunstein has published more than 200 peer-reviewed manuscripts, monographs, chapters and reviews dealing with human chorionic gonadotropin, pregnancy, testicular and ovarian physiology and pathophysiology, pituitary disorders and thyroid disease.

Dr. Braunstein is a member of a number of societies, including the Endocrine Society, the American Thyroid Association, the American Society for Clinical Investigation and the Association of American Physicians. He is a past Chair of the Endocrinologic and Metabolic Drugs Advisory Committee of the Food and Drug Administration (FDA) and currently serves as Special Advisor to that organization. Dr. Braunstein also served as Chair of the Endocrinology, Diabetes and Metabolism Subspecialty Boards for the American Board of Internal Medicine. The recipient of numerous awards and was named “Top Endocrinologist” by the Los Angeles Business Journal.

Dr. Abrahamson’s research interests include the management of patients with diabetes, and prevalence of silent coronary ischemia in patients with diabetes. He has co-authored guidelines for both the pharmacological and perioperative management of patients with diabetes and management of hyperglycemic emergencies, and has authored more than 50 papers, review articles and chapters related to diabetes.

Dr. Abrahamson has been cited in Boston Magazine as one of Boston’s top doctors on numerous occasions and has delivered numerous invited lectures nationally and internationally on the management of diabetes. In 2010 he was the recipient of the Samuel Eichold II Memorial Award for contributions to Diabetes from the American College of Physicians.